Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9765446 | 1.00 | MEN1 (0.33) | MEN1RAB9AGFERKMT2A | |
| SCHEMBL9127507 | 0.88 | — | — | |
| SCHEMBL9127509 | 0.88 | — | — | |
| SCHEMBL19368641 | 0.71 | MEN1 (0.33) | MEN1RAB9AGFERKMT2A | |
| SCHEMBL9765459 | 0.68 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL13684179 | 0.68 | — | — | |
| SCHEMBL9765457 | 0.68 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL11348502 | 0.67 | CHRNB2 (0.35) | MEN1RAB9AGFERKMT2A | |
| SCHEMBL11348506 | 0.67 | CHRNB2 (0.35) | MEN1RAB9AGFERKMT2A | |
| SCHEMBL11255643 | 0.63 | RAB9A (0.35) | MEN1RAB9AGFERKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4988723-A | Hypotensive agents, vasodilation | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-01-29 | — | — | US | disclosed |
| CN-1038811-A | 1-benzopyran derivatives and preparation method thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1990-01-17 | — | — | CN | disclosed |
| EP-0344747-A1 | Benzopyran derivatives and processes for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-12-06 | — | — | EP | disclosed |